Department of Genetics and Molecular Biology of Bacteria, Federal State Budget Institution «National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya» of the Ministry of Health of the Russian Federation
Auto-generated profile, based on publicly available information
Alexandr L. Gintsburg
Department of Genetics and Molecular Biology of Bacteria, Federal State Budget Institution «National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya» of the Ministry of Health of the Russian Federation
Antibacterial photodynamic therapy (APDT) is a promising method of treatment of local infections, based on photochemical reaction of photosensitizer (PS) u
14 March 2020 in Epidemiology and Vaccinal Prevention
Эпидемиологический надзор за хроническими инфекциями легких, вызванными бактериями Burkholderia cepacia complex , бактериями рода Achromobacter, Pseudomonas аeruginosa и метициллинрезистентным Staphylococcus aureus , у больных муковисцидозом
Virus-neutralizing antibodies are one of the few treatment options for COVID-19. The evolution of SARS-CoV-2 virus has led to the emergence of virus variants with reduced sensitivity to some antibody-based therapies. The development of potent antibodies with a broad spectrum of neutralizing activity is urgently needed. Here we isolated a panel of single-domain antibodies that specifically bind to the receptor-binding domain of SARS-CoV-2 S glycoprotein. Three of the selected antibodies exhibiting most robust neutralization potency were used to generate dimeric molecules. We observed that these modifications resulted in up to a 200-fold increase in neutralizing activity. The most potent heterodimeric molecule efficiently neutralized each of SARS-CoV-2 variant of concern, including Alpha, Beta, Gamma, Delta and Omicron variants. This heterodimeric molecule could be a promising drug candidate for a treatment for COVID-19 caused by virus variants of concern.